 | • レポートコード：D0804-15908 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、104ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、酵素ポリADPリボースポリメラーゼ（PARP）阻害剤の世界市場を広く調査・分析し、今後の市場展望をまとめております。酵素ポリADPリボースポリメラーゼ（PARP）阻害剤の種類別市場規模（ニラパリブ（ゼジュラ）、オラパリブ（リンパルザ）、ルカパリブ（ルブラカ）、タラゾパリブ（タルゼナ））、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：AstraZeneca、Jeil、Abbvie、Pfizer、Hansoh、Takeda、Shin Poong、BeiGene、Clovis、Oncology ・地域別グローバル市場分析 2015年-2020年 ・酵素ポリADPリボースポリメラーゼ（PARP）阻害剤の北米市場（アメリカ、カナダ、メキシコ） ・酵素ポリADPリボースポリメラーゼ（PARP）阻害剤のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・酵素ポリADPリボースポリメラーゼ（PARP）阻害剤のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・酵素ポリADPリボースポリメラーゼ（PARP）阻害剤の南米市場（ブラジル、アルゼンチン） ・酵素ポリADPリボースポリメラーゼ（PARP）阻害剤の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ニラパリブ（ゼジュラ）、オラパリブ（リンパルザ）、ルカパリブ（ルブラカ）、タラゾパリブ（タルゼナ） ・用途別分析：病院薬局、小売薬局、オンライン薬局 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor market has been segmented into:
Niraparib (Zejula)
Olaparib (Lynparza)
Rucaparib (Rubraca)
Talazoparib (Talzenna)
By Application, Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor has been segmented into:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor market presented in the report. This section sheds light on the sales growth of different regional and country-level Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor market.
The report offers in-depth assessment of the growth and other aspects of the Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Share Analysis
Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor sales, revenue and market share for each player covered in this report.
The major players covered in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor are:
AstraZeneca
Jeil
Abbvie
Pfizer
Hansoh
Takeda
Shin Poong
BeiGene
Clovis
Oncology
1 Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Overview
1.1 Product Overview and Scope of Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor
1.2 Classification of Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor by Type
1.2.1 Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Market Share by Type in 2019
1.2.3 Niraparib (Zejula)
1.2.4 Olaparib (Lynparza)
1.2.5 Rucaparib (Rubraca)
1.2.6 Talazoparib (Talzenna)
1.3 Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market by Application
1.3.1 Overview: Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market by Regions
1.4.1 Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Status and Prospect (2015-2025)
2 Company Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AstraZeneca SWOT Analysis
2.1.4 AstraZeneca Product and Services
2.1.5 AstraZeneca Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue, Gross Margin and Market Share (2018-2019)
2.2 Jeil
2.2.1 Jeil Details
2.2.2 Jeil Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Jeil SWOT Analysis
2.2.4 Jeil Product and Services
2.2.5 Jeil Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue, Gross Margin and Market Share (2018-2019)
2.3 Abbvie
2.3.1 Abbvie Details
2.3.2 Abbvie Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Abbvie SWOT Analysis
2.3.4 Abbvie Product and Services
2.3.5 Abbvie Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue, Gross Margin and Market Share (2018-2019)
2.5 Hansoh
2.5.1 Hansoh Details
2.5.2 Hansoh Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Hansoh SWOT Analysis
2.5.4 Hansoh Product and Services
2.5.5 Hansoh Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue, Gross Margin and Market Share (2018-2019)
2.6 Takeda
2.6.1 Takeda Details
2.6.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Takeda SWOT Analysis
2.6.4 Takeda Product and Services
2.6.5 Takeda Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue, Gross Margin and Market Share (2018-2019)
2.7 Shin Poong
2.7.1 Shin Poong Details
2.7.2 Shin Poong Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Shin Poong SWOT Analysis
2.7.4 Shin Poong Product and Services
2.7.5 Shin Poong Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue, Gross Margin and Market Share (2018-2019)
2.8 BeiGene
2.8.1 BeiGene Details
2.8.2 BeiGene Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 BeiGene SWOT Analysis
2.8.4 BeiGene Product and Services
2.8.5 BeiGene Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue, Gross Margin and Market Share (2018-2019)
2.9 Clovis
2.9.1 Clovis Details
2.9.2 Clovis Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Clovis SWOT Analysis
2.9.4 Clovis Product and Services
2.9.5 Clovis Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue, Gross Margin and Market Share (2018-2019)
2.10 Oncology
2.10.1 Oncology Details
2.10.2 Oncology Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Oncology SWOT Analysis
2.10.4 Oncology Product and Services
2.10.5 Oncology Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Players Market Share
3.2.2 Top 10 Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Market Share by Regions
4.2 North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
4.3 Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
4.5 South America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
5 North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue by Countries
5.1 North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue by Countries (2015-2020)
5.2 USA Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
5.3 Canada Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
5.4 Mexico Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
6 Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue by Countries
6.1 Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue by Countries (2015-2020)
6.2 Germany Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
6.3 UK Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
6.4 France Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
6.5 Russia Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
6.6 Italy Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue by Countries
7.1 Asia-Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue by Countries (2015-2020)
7.2 China Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
7.3 Japan Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
7.4 Korea Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
7.5 India Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
8 South America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue by Countries
8.1 South America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue by Countries (2015-2020)
8.2 Brazil Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
8.3 Argentina Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor by Countries
9.1 Middle East & Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue by Countries (2015-2020)
9.2 Saudi Arabia Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
9.3 UAE Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
9.4 Egypt Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
9.5 South Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Market Share by Type (2015-2020)
10.2 Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Forecast by Type (2019-2024)
10.3 Niraparib (Zejula) Revenue Growth Rate (2015-2025)
10.4 Olaparib (Lynparza) Revenue Growth Rate (2015-2025)
10.5 Rucaparib (Rubraca) Revenue Growth Rate (2015-2025)
10.6 Talazoparib (Talzenna) Revenue Growth Rate (2015-2025)
11 Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Segment by Application
11.1 Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Market Share by Application (2015-2020)
11.2 Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacies Revenue Growth (2015-2020)
11.4 Retail Pharmacies Revenue Growth (2015-2020)
11.5 Online Pharmacies Revenue Growth (2015-2020)
12 Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size Forecast (2021-2025)
12.1 Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size Forecast (2021-2025)
12.2 Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Forecast by Regions (2021-2025)
12.3 North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Market Forecast (2021-2025)
12.4 Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Market Forecast (2021-2025)
12.6 South America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. AstraZeneca Corporate Information, Location and Competitors
Table 6. AstraZeneca Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Major Business
Table 7. AstraZeneca Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Total Revenue (USD Million) (2017-2018)
Table 8. AstraZeneca SWOT Analysis
Table 9. AstraZeneca Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Product and Solutions
Table 10. AstraZeneca Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Jeil Corporate Information, Location and Competitors
Table 12. Jeil Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Major Business
Table 13. Jeil Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Total Revenue (USD Million) (2018-2019)
Table 14. Jeil SWOT Analysis
Table 15. Jeil Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Product and Solutions
Table 16. Jeil Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Abbvie Corporate Information, Location and Competitors
Table 18. Abbvie Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Major Business
Table 19. Abbvie Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Total Revenue (USD Million) (2017-2018)
Table 20. Abbvie SWOT Analysis
Table 21. Abbvie Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Product and Solutions
Table 22. Abbvie Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Pfizer Corporate Information, Location and Competitors
Table 24. Pfizer Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Major Business
Table 25. Pfizer Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Total Revenue (USD Million) (2017-2018)
Table 26. Pfizer SWOT Analysis
Table 27. Pfizer Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Product and Solutions
Table 28. Pfizer Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Hansoh Corporate Information, Location and Competitors
Table 30. Hansoh Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Major Business
Table 31. Hansoh Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Total Revenue (USD Million) (2017-2018)
Table 32. Hansoh SWOT Analysis
Table 33. Hansoh Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Product and Solutions
Table 34. Hansoh Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Takeda Corporate Information, Location and Competitors
Table 36. Takeda Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Major Business
Table 37. Takeda Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Total Revenue (USD Million) (2017-2018)
Table 38. Takeda SWOT Analysis
Table 39. Takeda Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Product and Solutions
Table 40. Takeda Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Shin Poong Corporate Information, Location and Competitors
Table 42. Shin Poong Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Major Business
Table 43. Shin Poong Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Total Revenue (USD Million) (2017-2018)
Table 44. Shin Poong SWOT Analysis
Table 45. Shin Poong Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Product and Solutions
Table 46. Shin Poong Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. BeiGene Corporate Information, Location and Competitors
Table 48. BeiGene Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Major Business
Table 49. BeiGene Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Total Revenue (USD Million) (2017-2018)
Table 50. BeiGene SWOT Analysis
Table 51. BeiGene Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Product and Solutions
Table 52. BeiGene Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Clovis Corporate Information, Location and Competitors
Table 54. Clovis Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Major Business
Table 55. Clovis Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Total Revenue (USD Million) (2017-2018)
Table 56. Clovis SWOT Analysis
Table 57. Clovis Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Product and Solutions
Table 58. Clovis Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Oncology Corporate Information, Location and Competitors
Table 60. Oncology Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Major Business
Table 61. Oncology Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Total Revenue (USD Million) (2017-2018)
Table 62. Oncology SWOT Analysis
Table 63. Oncology Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Product and Solutions
Table 64. Oncology Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue (Million USD) by Players (2015-2020)
Table 66. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Share by Players (2015-2020)
Table 67. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Market Share by Regions (2015-2020)
Table 69. North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue by Countries (2015-2020)
Table 70. North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Market Share by Countries (2015-2020)
Table 71. Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue by Countries (2015-2020)
Table 74. South America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Market Share by Countries (2015-2020)
Table 77. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue (Million USD) by Type (2015-2020)
Table 78. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Share by Type (2015-2020)
Table 79. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Forecast by Type (2021-2025)
Table 80. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue by Application (2015-2020)
Table 81. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Share by Application (2015-2020)
Table 82. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Forecast by Application (2021-2025)
Table 83. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Picture
Figure 2. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Market Share by Type in 2019
Figure 3. Niraparib (Zejula) Picture
Figure 4. Olaparib (Lynparza) Picture
Figure 5. Rucaparib (Rubraca) Picture
Figure 6. Talazoparib (Talzenna) Picture
Figure 7. Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Market Share by Application in 2019
Figure 8. Hospital Pharmacies Picture
Figure 9. Retail Pharmacies Picture
Figure 10. Online Pharmacies Picture
Figure 11. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Market Share in 2019
Figure 20. Global Top 10 Players Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Market Share by Regions (2015-2020)
Figure 24. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Market Share by Regions in 2018
Figure 25. North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
Figure 26. Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
Figure 28. South America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
Figure 30. North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Market Share by Countries (2015-2020)
Figure 31. North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Market Share by Countries in 2019
Figure 32. USA Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
Figure 33. Canada Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
Figure 35. Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Market Share by Countries in 2019
Figure 37. Germany Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
Figure 38. UK Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
Figure 39. France Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
Figure 40. Russia Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
Figure 41. Italy Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Market Share by Countries in 2019
Figure 44. China Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
Figure 45. Japan Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
Figure 46. Korea Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
Figure 47. India Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
Figure 49. South America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Market Share by Countries (2015-2020)
Figure 50. South America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Market Share by Countries in 2019
Figure 51. Brazil Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
Figure 56. UAE Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue and Growth Rate (2015-2020)
Figure 59. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Share by Type (2015-2020)
Figure 60. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Share by Type in 2019
Figure 61. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Share Forecast by Type (2021-2025)
Figure 62. Global Niraparib (Zejula) Revenue Growth Rate (2015-2020)
Figure 63. Global Olaparib (Lynparza) Revenue Growth Rate (2015-2020)
Figure 64. Global Rucaparib (Rubraca) Revenue Growth Rate (2015-2020)
Figure 65. Global Talazoparib (Talzenna) Revenue Growth Rate (2015-2020)
Figure 66. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Share by Application (2015-2020)
Figure 67. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Share by Application in 2019
Figure 68. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Share Forecast by Application (2021-2025)
Figure 69. Global Hospital Pharmacies Revenue Growth Rate (2015-2020)
Figure 70. Global Retail Pharmacies Revenue Growth Rate (2015-2020)
Figure 71. Global Online Pharmacies Revenue Growth Rate (2015-2020)
Figure 72. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Market Forecast (2021-2025)
Figure 76. Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Market Forecast (2021-2025)
Figure 78. South America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
ニコチンアミドリボース（NR）の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Nicotinamide Ribose (NR) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Nicotinamide Ribose …- シクロオキシゲナーゼ2阻害剤の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Cyclooxygenase 2 Inhibitor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cyclooxygenase 2 I…
- 精製用腐食防止剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Corrosion Inhibitor for Refining market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Corrosion In…
- 精製用腐食防止剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Corrosion Inhibitor for Refining market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Corrosion In…
- 標準型酵素キットの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Enzyme Standard Instrument market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Enzyme Standard In…